CKLIFE SCIENCES released its interim results, reporting a loss attributable to shareholders of HKD 150 million, a year-on-year turnaround from profit to loss
CKLIFE SCIENCES released its mid-term results for 2025, with revenue of HKD 2.606 billion, a year-on-year decrease of 1.14%. The company's loss attributable to shareholders was HKD 150 million, compared to a profit of HKD 1.001 million in the same period last year, resulting in a loss per share of HKD 1.57. The reason for the loss instead of profit is the company's increased investment in research and development, which rose from HKD 72.9 million in 2024 to HKD 235.3 million in 2025, an increase of HKD 162.4 million to accelerate the research process
According to the Zhitong Finance APP, CKLIFE SCIENCES (00775) released its interim results for 2025, reporting revenue of HKD 2.606 billion, a year-on-year decrease of 1.14%. The company's loss attributable to shareholders was HKD 150 million, compared to a profit of HKD 1.001 million in the same period last year; the loss per share was HKD 1.57.
The shift from profit to loss in the first half of 2024 compared to the same period in 2025 is attributed to the company's earlier decision to increase R&D investment, with related expenditures rising from HKD 72.9 million in 2024 to HKD 235.3 million in 2025, indicating an increase of HKD 162.4 million in investment in research projects to accelerate progress
